SUTENT: payments to doctors
Payments that named SUTENT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $295K
- Providers
- 1,461
- Transactions
- 2,395
- Average per transaction
- $123
The per-transaction average — $123 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,461 providers the average total is $202, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $289,823 | 98.1% |
| Whitehall International Inc | $4,929 | 1.7% |
| Pfizer Pharmaceuticals LLC | $589 | 0.2% |